[Evaluation of therapeutic activity of a new pharmacologic combination in patients with chronic liver and debilitating diseases].
D000328:Adult; D000368:Aged; D000880:Anthraquinones / Q000627:therapeutic use*; D002208:Caproates / Q000627:therapeutic use*; D002400:Cathartics / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D008110:Liver Extracts / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D011422:Propionates / Q000627:therapeutic use
D000880:Anthraquinones; D002208:Caproates; D002400:Cathartics; D008110:Liver Extracts; D009281:Naphthalenes; D010879:Piperazines; D011422:Propionates
Valutazione clinica dell'attività terapeutica di una nuova associazione farmacologica in pazienti affetti da epatopatie croniche e malattie debilitanti.